Example: Heart Attack

Clinical Trials Sponsored by Fovea Pharmaceuticals SA

Total 4 results

NCT01319487

Completed

Safety and Efficacy Study of Topical Administration of FOV2304 (High Dose or Low Dose) for the Treatment of Center-involving Clinically Significant Macular Edema Associated With Diabetic Retinopathy

Conditions: Diabetic Macular Edema
NCT01120132

Completed

Study Evaluating the Efficacy of Administration of Cyclosporine (Low Dose and High Dose) and Prednisolone Acetate Compared to Its Components and Vehicle in Patients With Allergic Conjunctivitis

Conditions: Allergic Conjunctivitis
NCT00969293

Terminated

Study to Assess the Safety and Tolerability of a Single Administration of FOV2302 (Ecallantide) in Patients With Macular Edema Associated With Central Retinal Vein Occlusion

Conditions: Macular Edema; Central Retinal Vein Occlusion
NCT00833495

Completed

Evaluation of Efficacy of Coadministration of FOV1101-00 and Prednisolone Acetate in Patients With Mild Ongoing Ocular Allergic Inflammation

Conditions: Allergic Conjunctivitis